Aimmune治疗(AIMT)

Zuluzulu2019-02-14 13:50

DBV Rejoins Peanut Allergy Treatment Race, But Aimmune Takes the Lead
Frank Vinluan 2/13/19
[Updated 9:20 p.m., see below.] DBV Technologies is jumping back into the race to bring an FDA-approved peanut allergy treatment to the market, but it might not be enough to be...查看全文

Zuluzulu2019-02-03 19:33

6 Biotech Stocks to Watch Now Here are six stocks that could pop or drop in 2019 based on these fast-approaching catalysts. Todd Campbell (TMFEBCapital) Feb 1, 2019 at 9:48AM Big news could cause these biotech stocks to go up or down. Biotech's biggest stories this year i...查看全文

EvergreenHall未然2019-01-24 01:12

$Aimmune治疗(AIMT)$ 花生酱跌回来了，买点抹面包查看全文

牛唐2019-01-23 22:45

$Aimmune治疗(AIMT)$ 12月21号报的BLA，FDA上班后大概率会给他一个PR，3月底还有topline，连续两个催化剂，且现在的股价还是52周最低附近$雀巢(NSRGY)$查看全文

网络异常请稍后再试2019-01-15 12:23

$Aimmune治疗(AIMT)$
Aimmune Therapeutics (NASDAQ:AIMT) discloses that the FDA informed it that its review of its marketing application seeking approval for AR101 for the treatment of peanut allergy is on hold while the federal government is shut down. It will initiate...查看全文

美股医药Z博士2018-11-14 02:56

$Aimmune Therapeutics, Inc.(AIMT)$ 公司的III期临床数据针对花生过敏，结果优异，大概率通过。目前市值处于较低位置，而马上Q4会有多个催化剂，如BLA的申请。昨天，雀巢刚刚以30块左右的价格增持。看好该股后续一路扶摇直上。查看全文

忘江2018-10-21 10:03

$Aimmune Therapeutics, Inc.(AIMT)$ 感觉这个公司的药治疗时间太长，易用性很不好。如果一个人已经懂事了，则不吃花生就是；如果没懂事，则还要大人监督用药，也不方便。查看全文

忘江2018-10-12 11:55

$Aimmune Therapeutics, Inc.(AIMT)$  
Second Quarter Highlights
AR101: Pivotal-stage biologic for the treatment of peanut allergy
 
•
Announced new clinical data at the Congress of the European Academy of Allergy, Asthma, and Immunology (EAACI) showing e...查看全文

Takeabreak2018-10-03 21:29

$Aimmune Therapeutics, Inc.(AIMT)$ 差不多52w low 此时不进，待何时查看全文

牛唐2018-06-23 10:36

$Aimmune Therapeutics, Inc.(AIMT)$ 下半年topline公布后，会被 $雀巢(NSRGY)$ 收购吗查看全文

$Aimmune治疗(AIMT)$ 8-K Current report, items 1.02, 2.01, 2.04, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-20-272122  Act: 34  Size: 258 KB 网页链接

$Aimmune治疗(AIMT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-20-028359  Size: 9 KB 网页链接

$Aimmune治疗(AIMT)$ 内部交易: 2020-10-13,10% Owner,Societe des Produits Nestle S. ,买入,54117287普通股, $34.50

$Aimmune治疗(AIMT)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-20-268644  Act: 33  Size: 20 KB 网页链接

$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268646  Act: 33  Size: 25 KB 网页链接

$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268648  Act: 33  Size: 25 KB 网页链接

$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268649  Act: 33  Size: 25 KB 网页链接

$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268654  Act: 33  Size: 25 KB 网页链接

$Aimmune治疗(AIMT)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-20-268640  Act: 33  Size: 20 KB 网页链接

$Aimmune治疗(AIMT)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-20-268641  Act: 33  Size: 25 KB 网页链接